Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00215553 · ClinicalTrials.gov registry record · Phase 2
KL₄Surfactant Treatment in Patients With ARDS
A Phase 2 study, sponsored by Windtree Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 124
- Enrollment target
NCT00215553 is a Phase 2 study that was terminated before completion, run by Windtree Therapeutics. The registered enrollment target is 124 participants.
The verdict
NCT00215553, a Phase 2 study, was terminated before completion, sponsored by Windtree Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 124 participants
- Enrollment target
Study Summary
Lung wash with KL₄Surfactant of individual lung segments using a bronchoscope compared to usual care alone consisting primarily of assisted (mechanical) ventilation in patients with acute respiratory distress syndrome(ARDS).
Interventions
- DRUG A.1 Lucinactant
- OTHER B.3 SoC
- DRUG A.2 Lucinactant
- DRUG A.3 Lucinactant
- DRUG A.4 Lucinactant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2001-05 |
| Est. Completion | 2006-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00215553
The ClinicalTrials.gov registry entry for NCT00215553 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Windtree Therapeutics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which A.1 Lucinactant is the first listed.
NCT00215553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00215553 about?
NCT00215553 is a clinical study titled "KL₄Surfactant Treatment in Patients With ARDS". Lung wash with KL₄Surfactant of individual lung segments using a bronchoscope compared to usual care alone consisting primarily of assisted (mechanical) ventilation in patients with acute respiratory distress syndrome(ARDS).
What is the current status of trial NCT00215553?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 124 participants. The study started on 2001-05. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00215553?
The interventions under investigation include: A.1 Lucinactant (DRUG), B.3 SoC (OTHER), A.2 Lucinactant (DRUG), A.3 Lucinactant (DRUG), A.4 Lucinactant (DRUG).
Who is sponsoring clinical trial NCT00215553?
This trial is sponsored by Windtree Therapeutics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.